The Euro Diagnostica group of companies today announced a corporate rebrand to Svar Life Science. The companies formerly known as Euro Diagnostica AB and Wieslab AB are now operational as “Svar Life Science AB” and “Wieslab AB, a Svar Life Science company”. The rebranding consists of: a new corporate brand structure, a new slogan, and a new focus for the group.
As a global supplier and partner within drug discovery and clinical diagnostics, the Svar Life Science group of companies have more than 30 years of experience serving the life science market with products and laboratory services aimed at helping customers move forward in the drug development process.
The group will continue to find and harness the optimal solutions through mergers, acquisitions, in-house innovation, industry collaboration and knowledge exchange and the adoption of a new brand signifies new beginnings.
In Swedish Svar means answers and the brand reflects the evolution of the company, the vision for the future as well as a strong Scandinavian heritage and the attributes associated with it: reliability, quality, expertise, responsiveness and focus on people.
With this corporate rebranding, the Svar Life Science group of companies are strengthening their focus of delivering a full suite of products and services to life science companies which is reflected in the new tagline, "Answers in Life Science."
Ron Long, CEO, Svar Life Science, said:
“This rebrand represents a significant step in the company’s evolution and forms a part of our strategy of focusing our product portfolio and core technologies to deliver high quality solutions, the best analytical technologies and platforms for drug development, clinical research and routine diagnosis – answering to the needs in drug discovery and clinical diagnostics today.”
About Svar Life Science
Svar Life Science is a Swedish life science company that invents, develops and applies the best analytical technologies for drug development and clinical research, and establishes practical platforms for routine diagnosis. You can be sure of our answers: we’ve been working right across the clinical diagnostic value chain for over 30 years.
Svar is your partner for researching diagnostic strategies for personalized medicine and developing companion diagnostics based on assays customized for you. Once the assays are established, you can use us for dedicated testing in early discovery, preclinical and clinical phases. Our special competence areas are autoimmune disease, inflammatory disease and cancer, with a focus on IBD and RA.
Svar Life Science:
Jörgen Dahlström, Chief Business Officer
T +46 40 53 76 08
Wieslab AB, a Svar Life Science company
Michael Akoh, Vice President Laboratory Services
T +46 40 53 76 31